These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15029258)

  • 1. Expression of Ephb2 and Ephb4 in breast carcinoma.
    Wu Q; Suo Z; Risberg B; Karlsson MG; Villman K; Nesland JM
    Pathol Oncol Res; 2004; 10(1):26-33. PubMed ID: 15029258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
    Nguyen TM; Arthur A; Hayball JD; Gronthos S
    Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of ephrin-Bs and their receptors in colon carcinoma.
    Liu W; Ahmad SA; Jung YD; Reinmuth N; Fan F; Bucana CD; Ellis LM
    Cancer; 2002 Feb; 94(4):934-9. PubMed ID: 11920461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.
    Lee TH; Heo JH; Jeong JY; Lee GH; Park DS; Kim TH
    Yonsei Med J; 2021 Aug; 62(8):679-690. PubMed ID: 34296545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.
    Wu Q; Suo Z; Kristensen GB; Baekelandt M; Nesland JM
    Gynecol Oncol; 2006 Jul; 102(1):15-21. PubMed ID: 16499955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.
    Li X; Choi WW; Yan R; Yu H; Krasnoperov V; Kumar SR; Schuckman A; Klumpp DJ; Pan CX; Quinn D; Gill IS; Gill PS; Liu R
    PLoS One; 2014; 9(8):e105326. PubMed ID: 25148033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephrin‑B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis‑free survival in breast cancer.
    Magic Z; Sandström J; Perez-Tenorio G
    Int J Oncol; 2019 Dec; 55(6):1275-1286. PubMed ID: 31638179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
    Kuang SQ; Bai H; Fang ZH; Lopez G; Yang H; Tong W; Wang ZZ; Garcia-Manero G
    Blood; 2010 Mar; 115(12):2412-9. PubMed ID: 20061560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.
    Kumar SR; Singh J; Xia G; Krasnoperov V; Hassanieh L; Ley EJ; Scehnet J; Kumar NG; Hawes D; Press MF; Weaver FA; Gill PS
    Am J Pathol; 2006 Jul; 169(1):279-93. PubMed ID: 16816380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.
    Helbling PM; Saulnier DM; Brändli AW
    Development; 2000 Jan; 127(2):269-78. PubMed ID: 10603345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.
    Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R
    Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer.
    Husa AM; Magić Ž; Larsson M; Fornander T; Pérez-Tenorio G
    Oncotarget; 2016 Apr; 7(16):21362-80. PubMed ID: 26870995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
    Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
    Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Br J Cancer; 2008 Feb; 98(4):845-51. PubMed ID: 18231102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer.
    Takai N; Miyazaki T; Fujisawa K; Nasu K; Miyakawa I
    Oncol Rep; 2001; 8(3):567-73. PubMed ID: 11295082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localisation of ephrin-B1, EphB2, and EphB4 in the mouse testis during postnatal development.
    Gofur MR; Alam J; Ogawa K
    Reprod Biol; 2020 Sep; 20(3):321-332. PubMed ID: 32620380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.